Nu Holdings (NU) Insider Files Form 144 to Sell 20,000 Shares
Rhea-AI Filing Summary
Form 144 notice for Nu Holdings Ltd. (NU) shows that Henrique Camossa Saldanha Fragelli intends to sell 20,000 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $270,000 and an approximate sale date of 08/18/2025 on the NYSE. The shares were acquired as restricted stock vesting under a registered plan on 07/01/2022 and were received as compensation. The filing discloses that 20,000 of those shares were acquired on the vesting date and that the filer represents they have no undisclosed material adverse information about the issuer. The filing also reports three recent sales by the same person during the past three months totaling 40,000 shares for gross proceeds of $495,000.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider sale disclosure; planned sale size is immaterial relative to the issuer's outstanding shares.
This Form 144 documents a proposed sale of 20,000 common shares valued at $270,000 and prior sales of 40,000 shares totaling $495,000. The shares were originally acquired via restricted stock vesting as compensation on 07/01/2022. Given the issuer's reported share count of 4,818,658,640 shares outstanding, the planned sale represents a de minimis fraction of outstanding stock, suggesting limited direct impact on supply-demand dynamics. The filing fulfills SEC Rule 144 notice requirements and offers transparency into recent insider liquidity events without indicating undisclosed company-specific material information.
TL;DR: Proper compliance with Rule 144; prior sales disclosed and signer attests no undisclosed material info.
The notice identifies the selling person and broker and states the shares were granted as restricted stock vesting under a registered plan, with payment characterized as compensation. The filer signs the required attestation regarding lack of undisclosed material adverse information. From a governance perspective, the submission is a standard disclosure of insider selling activity and the prior three months of sales are properly reported. There is no indication in the filing of any governance irregularities or trading-plan references that would alter the interpretation of routine liquidity management.